Skip to Content

Etidronate use while Breastfeeding

Drugs containing Etidronate: Didronel, Didronel IV

Medically reviewed by Drugs.com. Last updated on April 22, 2021.

Etidronate Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because no information is available on the use of etidronate during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. However, absorption of etidronate by a breastfed infant is unlikely.

Drug Levels

Etidronate is poorly absorbed orally (average in adults 3% on an empty stomach, less with food), so absorption of etidronate by a breastfed infant is unlikely.

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Pamidronate

Substance Identification

Substance Name

Etidronate

CAS Registry Number

2809-21-4

Drug Class

  • Breast Feeding
  • Lactation
  • Bisphosphonates
  • Bone Density Conservation Agents
  • Diphosphonates

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.